132 related articles for article (PubMed ID: 16876821)
21. Docking protein Gab2 positively regulates glycoprotein VI-mediated platelet activation.
Yi Q; Suzuki-Inoue K; Asazuma N; Inoue O; Watson SP; Ozaki Y
Biochem Biophys Res Commun; 2005 Nov; 337(2):446-51. PubMed ID: 16198316
[TBL] [Abstract][Full Text] [Related]
22. A new monoclonal antibody, mAb 204-11, that influences the binding of platelet GPVI to fibrous collagen.
Moroi M; Mizuguchi J; Kawashima S; Nagamatsu M; Miura Y; Nakagaki T; Ito K; Jung SM
Thromb Haemost; 2003 Jun; 89(6):996-1003. PubMed ID: 12783112
[TBL] [Abstract][Full Text] [Related]
23. Palmitoylation at Cys595 is essential for PECAM-1 localisation into membrane microdomains and for efficient PECAM-1-mediated cytoprotection.
Sardjono CT; Harbour SN; Yip JC; Paddock C; Tridandapani S; Newman PJ; Jackson DE
Thromb Haemost; 2006 Dec; 96(6):756-66. PubMed ID: 17139370
[TBL] [Abstract][Full Text] [Related]
24. The platelet receptor GPVI mediates both adhesion and signaling responses to collagen in a receptor density-dependent fashion.
Chen H; Locke D; Liu Y; Liu C; Kahn ML
J Biol Chem; 2002 Jan; 277(4):3011-9. PubMed ID: 11723134
[TBL] [Abstract][Full Text] [Related]
25. Gain- and loss-of-function mutants confirm the importance of apical residues to the primary interaction of human glycoprotein VI with collagen.
O'Connor MN; Smethurst PA; Farndale RW; Ouwehand WH
J Thromb Haemost; 2006 Apr; 4(4):869-73. PubMed ID: 16405521
[TBL] [Abstract][Full Text] [Related]
26. A-Disintegrin-And-Metalloproteinase (ADAM) 10 Activity on Resting and Activated Platelets.
Facey A; Pinar I; Arthur JF; Qiao J; Jing J; Mado B; Carberry J; Andrews RK; Gardiner EE
Biochemistry; 2016 Mar; 55(8):1187-94. PubMed ID: 26840909
[TBL] [Abstract][Full Text] [Related]
27. The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to FcalphaR and the natural killer receptors.
Clemetson JM; Polgar J; Magnenat E; Wells TN; Clemetson KJ
J Biol Chem; 1999 Oct; 274(41):29019-24. PubMed ID: 10506151
[TBL] [Abstract][Full Text] [Related]
28. Highly potent anti-human GPVI monoclonal antibodies derived from GPVI knockout mouse immunization.
Matsumoto Y; Takizawa H; Gong X; Le S; Lockyer S; Okuyama K; Tanaka M; Yoshitake M; Tandon NN; Kambayashi J
Thromb Res; 2007; 119(3):319-29. PubMed ID: 16566959
[TBL] [Abstract][Full Text] [Related]
29. Design and humanization of a murine scFv that blocks human platelet glycoprotein VI in vitro.
Muzard J; Bouabdelli M; Zahid M; Ollivier V; Lacapère JJ; Jandrot-Perrus M; Billiald P
FEBS J; 2009 Aug; 276(15):4207-22. PubMed ID: 19558491
[TBL] [Abstract][Full Text] [Related]
30. Snake venom C-type lectins interacting with platelet receptors. Structure-function relationships and effects on haemostasis.
Lu Q; Navdaev A; Clemetson JM; Clemetson KJ
Toxicon; 2005 Jun; 45(8):1089-98. PubMed ID: 15876445
[TBL] [Abstract][Full Text] [Related]
31. Structural basis for platelet antiaggregation by angiotensin II type 1 receptor antagonist losartan (DuP-753) via glycoprotein VI.
Ono K; Ueda H; Yoshizawa Y; Akazawa D; Tanimura R; Shimada I; Takahashi H
J Med Chem; 2010 Mar; 53(5):2087-93. PubMed ID: 20158191
[TBL] [Abstract][Full Text] [Related]
32. Selective blockade of glycoprotein VI clustering on collagen helices.
O'Connor MN; Smethurst PA; Davies LW; Joutsi-Korhonen L; Onley DJ; Herr AB; Farndale RW; Ouwehand WH
J Biol Chem; 2006 Nov; 281(44):33505-10. PubMed ID: 16956881
[TBL] [Abstract][Full Text] [Related]
33. Expression of glycoprotein VI in vascular endothelial cells.
Sun B; Tao L; Lin S; Calingasan NY; Li J; Tandon NN; Yoshitake M; Kambayashi J
Platelets; 2003 Jun; 14(4):225-32. PubMed ID: 12850831
[TBL] [Abstract][Full Text] [Related]
34. Delineation of the region in the glycoprotein VI tail required for association with the Fc receptor gamma-chain.
Bori-Sanz T; Inoue KS; Berndt MC; Watson SP; Tulasne D
J Biol Chem; 2003 Sep; 278(38):35914-22. PubMed ID: 12847105
[TBL] [Abstract][Full Text] [Related]
35. Characterizing the binding of glycoprotein VI with nanobody 35 reveals a novel monomeric structure of glycoprotein VI where the conformation of D1+D2 is independent of dimerization.
Damaskinaki FN; Jooss NJ; Martin EM; Clark JC; Thomas MR; Poulter NS; Emsley J; Kellam B; Watson SP; Slater A
J Thromb Haemost; 2023 Feb; 21(2):317-328. PubMed ID: 36700508
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the interaction of platelet collagen receptor glycoprotein VI (GPVI) with collagen. A dimeric form of GPVI, but not the monomeric form, shows affinity to fibrous collagen.
Miura Y; Takahashi T; Jung SM; Moroi M
J Biol Chem; 2002 Nov; 277(48):46197-204. PubMed ID: 12356768
[TBL] [Abstract][Full Text] [Related]
37. Local delivery of soluble platelet collagen receptor glycoprotein VI inhibits thrombus formation in vivo.
Bültmann A; Herdeg C; Li Z; Münch G; Baumgartner C; Langer H; Kremmer E; Geisler T; May A; Ungerer M; Gawaz M
Thromb Haemost; 2006 May; 95(5):763-6. PubMed ID: 16676064
[TBL] [Abstract][Full Text] [Related]
38. A compound heterozygous mutation in glycoprotein VI in a patient with a bleeding disorder.
Hermans C; Wittevrongel C; Thys C; Smethurst PA; Van Geet C; Freson K
J Thromb Haemost; 2009 Aug; 7(8):1356-63. PubMed ID: 19552682
[TBL] [Abstract][Full Text] [Related]
39. The interaction of Fc alpha RI with IgA and its implications for ligand binding by immunoreceptors of the leukocyte receptor cluster.
Wines BD; Sardjono CT; Trist HH; Lay CS; Hogarth PM
J Immunol; 2001 Feb; 166(3):1781-9. PubMed ID: 11160224
[TBL] [Abstract][Full Text] [Related]
40. Snake venom probes of platelet adhesion receptors and their ligands.
Wijeyewickrema LC; Berndt MC; Andrews RK
Toxicon; 2005 Jun; 45(8):1051-61. PubMed ID: 15922774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
